// App-Quantinova.ai

209 : A trial emulation comparing thromboprophylaxis versus no thromboprophylaxis among ward-based patients with covid-19

Researchers

Presenter

  • Amit Kaura

Principal Investigators

  • Divaka Perera

  • Raj Kharbanda

  • Des Campbell

  • Adam Trickey

  • Riyaz S Patel

  • Nick Curzen

  • Stuart Grant

  • Iain Squire

  • Keith Channon

  • Jamil Mayet

  • Christopher Herbert

  • Tom Johnson

  • John Townend

  • Jonathan Sterne

  • Kevin O’Gallagher

Medical Centers

  • King’s College Hospital NHS Foundation Trust

  • South Tees Hospitals NHS Foundation Trust

  • Oxford University Hospitals NHS Foundation Trust

  • Imperial College London

  • University Hospital Southampton NHS Foundation Trust

  • The Royal Marsden NHS Foundation Trust

  • University Hospitals Bristol

  • University of Bristol

  • Kings College, London,

  • university Hospitals Birmingham NHS foundation trust

  • Glenfield Hospital, Department of Cardiovascular Sciences, Cardiovascular Research Centre,, Leiceste

  • University College London Hospitals NHS Foundation Trust, Ibadan, Nigeria

  • NIHR Imperial Biomedical Research Centre, Imperial College London and Imperial College Healthcare

  • University of Oxford

  • Leeds Teaching Hospitals NHS Trust

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Coronavirus disease

Biomarkers

  • N/A

Drug/Treatment

  • dalteparin Subcutaneous

  • Enoxaparin

  • Enoxaparin sodium

  • Tinzaparin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved